Roles
Professor of Neurology
Chief, Division of Cognitive Neurology
Director, Comprehensive Center for Brain Health
Director, Lewy Body Dementia Research Center of Excellence
-
Biography
James E. Galvin, M.D., M.P.H. is Professor of Neurology and Psychiatry & Behavioral Sciences at the University of Miami Miller School of Medicine. He is Division Chief for Cognitive Neurology, Founding Director of the Comprehensive Center for Brain Health, and Director and Principal Investigator of the Lewy Body Dementia Research Center of Excellence. Dr. Galvin has authored over 325 scientific publications (h-index=66) and 3 textbooks on healthy brain aging, cognitive health, Alzheimer’s disease, Lewy Body dementia, and related disorders. Dr. Galvin is principal investigator on 9 active NIH grants and has received over $100 Million in research funding from the National Institutes of Health, Disease Associations, Private and Family Foundations. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Teaching Interests
Dr Galvin and his colleagues at the Comprehensive Center for Brain Health (CCBH) develop unique training opportunities for students, residents, fellows, staff, and faculty to gain training, knowledge, and expertise in brain health and neurodegenerative diseases and provide structured mentoring opportunities for early-stage investigators on their path to research independence. CCBH also is actively involved in training the next generation of clinicians and scientists and providing educational programming for the lay community. In the past 2 years, CCBH has conducted over 60 programs reaching over 4000 individuals. -
Research Interests
The Comprehensive Center for Brain Health (CCBH), part of the Department of Neurology at the University of Miami Miller School of Medicine, was created to provide a robust and collaborative infrastructure to study brain health and the risk of neurodegenerative diseases such as Mild Cognitive Impairment, Alzheimer’s Disease, Parkinson’s Disease, Lewy Body Dementia, Frontotemporal Degeneration, Vascular Cognitive Impairment, and Chronic Traumatic Encephalopathy. CCBH uses a transdisciplinary approach for our research projects and clinical care, combining the best practices of neurology, gerontology, cognitive neuroscience, nursing, social work, psychotherapy, integrative nutrition, mindfulness, lifestyle modification, physical therapy, public health, medical education, epidemiology, biochemistry, genetics, data science, and biostatistics. In addition to our NIH-funded research, CCBH has a comprehensive clinical arm to evaluate, diagnosis and treat individuals with all forms of cognitive impairment, providing a personalized and tailored approach to brain health with a focus of improving the healthspan for all our patients.
The Healthy Brain Initiative (HBI) Project is at the heart of CCBH’s mission. Funded by multiple federal and private grants, HBI is a longitudinal study to deeply phenotype individuals, determine factors that contribute the cognitive resilience and healthy brain aging, examine factors that increase vulnerability and risk of neurodegenerative disease, and explore social and medical determinants of brain health in diverse populations including African Americans, Afro-Caribbeans, Hispanics, rural communities, American Indians, Native Hawaiians, and Pacific Islanders. The ultimate goal of HBI is to develop dementia prevention programs using a precision medicine-like approach with personalized tailored interventions by combining innovative implementation of culturally adapted health literacy assessments alongside comprehensive “phenotype-to-genotype” community-based healthcare research. HBI supports a number of affiliated studies in Lewy Body Dementia, Alzheimer's disease, and mild cognitive impairment, including pragmatic studies using electronic health records and patient-reported outcomes, qualitative research on health disparities and stigma, creation of novel plasma and behavior-based biomarkers of neurodegenerative disease, and testing novel therapeutics and diagnostics. -
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.